Two people walked into a clinic this month with almost exactly the same blood-pressure reading. And for one of them it was good news. For the other, it was the reason she's in a cast.
The first is a man in his mid-forties. His monitor says 118 over 76 — and he's frightened. His dad had a heart attack at fifty, he's been reading online that anything creeping toward 120 is a warning sign, and he's come in convinced something is quietly going wrong inside him. The second is a woman in her eighties. She's on two blood-pressure tablets, and her reading is a tidy 120 over 80 — the exact number we're all told to aim for. Last month she got up out of her chair, the room went grey, and she went straight down. She broke her wrist. She's still in the cast.
Same number. For him, it's a gift. For her, it's a hazard. And before you decide this is an article about old people — it isn't. That frightened man in his forties is you, or someone you love, right now. The woman in the cast is you, or your parents, in thirty years. What decides which one you are isn't the number of birthdays you've had — it's something we'll come back to, called frailty. By the end of this, you'll know your side of the line, and exactly what to do about it.
Table of Contents
- Why we lower blood pressure at all
- Who was actually in that trial? (And is your 120 really 120?)
- Lower really is better — the 2024 trial that closed the gap
- The other end of the tightrope — why it's frailty, not age
- The young end — why a low number is good news
- Step one: make sure the number is even real
- Step two: your side of the tightrope and the levers you control
- Step three: the conversation to have with your doctor
- The right number isn't printed on a chart
- References
Why we lower blood pressure at all
To see why one identical number can mean opposite things, start with the question both of those patients are really asking: why do we chase this number at all? The answer is simple — less pressure on the vessels means fewer heart attacks and strokes.
Quick note before we go on. I'm a family-medicine doctor, and I make these articles to help you understand the evidence — not to replace your own doctor. I'm not your physician, so talk to yours before you change anything about your blood pressure or your medication.
The trial that made “lower” the goal was SPRINT, published in 2015. In 9,361 high-risk adults, aiming for a systolic under 120 beat aiming for under 140 on hard outcomes: the intensive group had 1.65% of patients per year suffer a major cardiovascular event, versus 2.19% per year in the standard group — a hazard ratio of 0.75 — and lower all-cause death, at a hazard ratio of 0.73 [1].
Now, you'll see that written up as a “27% reduction,” and I want to be straight with you, because that's the relative number and it always sounds bigger than what you actually feel. In plain terms, it's about half a percentage point fewer events per year. Put another way: you'd treat roughly 61 people to prevent one cardiovascular event, and about 90 to prevent one death, over the three-and-a-bit years of the trial [1]. That's a real benefit — but it's a modest one, and anyone quoting you the 27% without that context is only telling you half the story.
And one quick bit of precision, because it trips everyone up. That famous “120 over 80” isn't a target — it's the ceiling of normal. Once you're actually being treated, the guideline number doctors aim for is under 130 over 80. So when I say “aim for under 120,” I'm talking about a specific, high-risk group in a specific trial — not a rule for everybody. It sounds settled — so why isn't the answer just “everyone aim for 120”? The first catch is who was actually in that trial.
Who was actually in that trial? (And is your 120 really 120?)
Before you take that number to heart, two things buried in the fine print completely change what it means for you.
The first is the exclusions. SPRINT deliberately left out the exact people who are often most worried. No one with diabetes. No one with a prior stroke. And not the frail [1]. So the headline result was never tested on some of the people most likely to be reading this.
The second is the measurement — and this is the single most common question I get on this topic. SPRINT measured blood pressure with an automated device while the patient sat alone in a quiet room, and that reads about 5 to 10 mmHg lower than the cuff on your doctor's wall [2]. So the trial's “under 120” isn't the “under 120” you actually see in clinic. Hold onto that — we'll come back to how to measure your own number properly.
Lower really is better — the 2024 trial that closed the gap
So does “lower is better” hold up once you add back the diabetics and stroke patients SPRINT excluded? The newest and largest trial did exactly the one thing SPRINT wouldn't — it let the sicker patients in.
ESPRIT, published in The Lancet in 2024, enrolled 11,255 patients, this time including people with diabetes and prior strokes. And aiming under 120 still won — on events (hazard ratio 0.88), on cardiovascular death (0.61), and on death from any cause (0.79) [3]. It's the biggest, freshest piece of evidence in this whole debate, and it points the same direction as SPRINT.
I want to keep this honest rather than cherry-picked, so here's the counter-example. Back in 2010, ACCORD tried the same under-120 target in people with type 2 diabetes and missed its primary outcome: a hazard ratio of 0.88 with a p-value of 0.20, although strokes did fall [4]. The best read is that it was underpowered — ESPRIT later showed the benefit — but it's only fair to name it. So if aiming lower keeps winning — in the fit, in the frail-ish, in diabetics, in stroke survivors — why on earth would anyone ever need to aim higher? Because there's a second cliff. And it's on the other side of the road.
The other end of the tightrope — why it's frailty, not age
Push the wrong person's pressure too low, and you don't prevent a stroke. You cause a fall. This is the part about your parents — and about you, later. Watch how the target flips.
The mechanism is plain enough. In a frail older person, drop the pressure, they stand up, blood doesn't reach the brain fast enough, they go grey and go down — and a broken hip is not a small event. The numbers behind each link in that chain are sobering. In frail nursing-home residents over 80, those with a systolic under 130 who were on two or more blood-pressure drugs had a 78% higher risk of dying over two years [5]. A meta-analysis of about fifty thousand people found that orthostatic hypotension — the blood-pressure drop when you stand — carried a 73% higher odds of falling [6]. And a broken hip itself carries a one-year mortality of around 20 to 30 percent [7].
There's a floor at the bottom number too. Your coronary arteries fill during diastole, so if the bottom number drops too far — below about 60 — it may starve the heart's own blood supply. That's the so-called J-curve. But I want to be careful here: this shows up in observational data, not proven cause-and-effect [8].
And here's the part almost everyone gets wrong — including plenty of doctors. This is not about age. When the trials looked at their own fittest patients over seventy-five — the ones who were sent for the under-120 target — those people still got the benefit (hazard ratio 0.66 for events, 0.67 for death), and they did not fall more than anyone else (4.9% versus 5.5%) [9]. So the falls story was never really an age story. It's a frailty story. It's not that the birthday flips the target — it's whether the body has become fragile. The honest boundary is worth stating out loud: the falls-and-over-treatment harm rests on observational data in frail people, while the trials studied relatively fit elders. So the rule is “frailty, orthostatic symptoms, tolerance,” never “old means aim higher.”
Picture that woman again. Somewhere along the way, someone added a second tablet to push her pressure down to the number on the chart. And then nobody ever went back to ask whether she still needed it — not after she lost a little weight, not the first time she felt dizzy standing up. Her reading looked perfect right up until the morning it put her on the floor. The target was the only thing anyone was watching. She was the thing they missed.
The young end — why a low number is good news
Now the good news — and it's for that worried man from the very start. If you're younger and your reading is low, you're the one who gets to relax.
The risk here is continuous — there's no magic safe threshold. Across about a million adults, cardiovascular death roughly doubles for every 20 points of systolic pressure, all the way down to 115 over 75 [10]. A lower number simply tracks with lower lifetime risk.
And a lifetime of lower pressure beats anything a three-year trial can show. Genetic data suggest that lifelong lower blood pressure compounds into dramatically lower lifetime cardiovascular risk [11]. One honest guard on that, though: this is lifelong exposure, effectively from birth — it is not the effect of a pill started in mid-life. So two ends of one tightrope. How do you find your footing on it? Here's the framework.
Step one: make sure the number is even real
Before you argue about whether your target should be 120 or 130, here's the uncomfortable truth: most people are chasing a number that's simply wrong. The white-coat effect and bad cuff technique wreck the reading, and the number on the machine may not be your real number. In fact the doctor's office is often the worst place to measure it — for many people the reading jumps just from being there, which is exactly why the guidance now says to measure it at home, where it's real, before anyone decides your target [12].
The good news is that this part is fully in your control. Sit quietly for five minutes first; back and feet supported, arm resting at heart level, the right cuff size, no talking, empty bladder, and no coffee or exercise for half an hour beforehand [12].
Don't trust one number, either. The protocol that works is two readings, morning and evening, for a week — then throw out the first day and average the rest [13]. Decisions rest on that average, never on one alarming reading.
And technique matters more than people think, because bad technique doesn't just add noise — it biases the number upward, toward over-diagnosis and over-treatment. Get these wrong and the number lies to you, almost always too high. Talking during the reading can add up to nineteen points; letting your arm hang can add over twenty; a full bladder, crossed legs, the wrong cuff — each quietly inflates it [14]. Those are ranges across studies, not fixed values, and they push the number in one direction: up.
Step two: your side of the tightrope and the levers you control
Once the number is real, you can find yourself on that tightrope — and there's a surprising amount you can do about your number without a single prescription. Think of it as a simple two-way sort. Younger, tolerates a low reading, no dizziness on standing? Aiming lower is fine — be glad. Frail, falls, symptomatic drops on standing, or a very low bottom number with heart disease? That points toward a softer, higher target.
Then there are the levers that are genuinely yours, all evidence-based and prescription-free. Pooling 270 randomised trials, aerobic exercise lowered systolic pressure by about four and a half points, while isometric holds — think wall-sits — came out on top at roughly eight points [15]. I'd flag the isometric figure carefully: it's the biggest number but rests on the smallest, shortest trials with no heart-attack-or-stroke outcome data yet, so treat it as a promising, time-cheap option rather than proven event reduction — aerobic exercise is the one carrying the hard-outcome evidence. Every kilogram of weight lost drops systolic pressure by about one point, so a five-kilo loss is worth roughly four to five points [16]. Cutting salt by about four grams a day lowers systolic pressure by just over four points — and about twice that in people who already have high blood pressure [17].
The DASH eating pattern — where the original trial actually provided the food — lowered systolic pressure by 5.5 points overall, and 11.4 points in people who started with hypertension [18]. In people drinking six or more drinks a day, cutting back by about half lowered systolic pressure by five and a half points [19]. And eating more potassium — the fruit-and-vegetable side of DASH — lowered systolic pressure by about three and a half points in people with high readings [20]. One important framing point: these effects are not simply additive. Treat each as “roughly this much on its own,” the combination as “meaningfully more, but you can't just add them up” — and note the effects are consistently larger in people who start with high blood pressure.
There's one hard catch in that whole list. Potassium is dietary and doctor-guided — never a supplement to self-prescribe. If you're on certain blood-pressure pills, like ACE-inhibitors or ARBs, or you have kidney problems, loading up on potassium can push it dangerously high [21]. That one's a conversation with your doctor, not a supplement you add on your own. But everything else here you can start today. The way I think about it: every point you take off with your own two feet is a point a pill doesn't have to.
Step three: the conversation to have with your doctor
This last step is where you stop being a passenger and start advocating for yourself. The questions to bring are simple: “Given my age, my risk, and how I tolerate it — what's the right target for me?” “Am I getting dizzy standing up on this dose?” And, if things have changed: “If I've lost weight or my health has shifted, should we reassess?”
And if you feel awkward asking, know that individualising the target is mainstream, not fringe — the guideline bodies themselves disagree. The 2017 American guidelines set the treatment target at under 130 over 80 [22]. Another major body — the American College of Physicians and the family-medicine group — argued for a more relaxed under-150 in people over 60, and told doctors to individualise [23]. When the experts openly disagree, you have every right to ask where you personally land.
One caution, and it's the only real “don't” in this whole article: don't change your prescription doses on your own. You work the target out with your doctor, together. But everything else here — measuring your number properly, walking, the salt, the potassium-rich food — that's yours to start today.
The right number isn't printed on a chart
Remember our two patients? The man in his forties, staring at 118 over 76 and bracing for bad news — he can breathe. For him, that low number is a head start, and the worst thing he could do is treat it like a disease. And the woman in the cast? Her family should walk into her next appointment and ask one simple question: given how she's doing now, is this still the right target — and does she still need both tablets?
Because here's where I land. The right blood-pressure number isn't printed on a chart. It's the balance between the strokes we prevent and the falls we cause. To me, the evidence is clear that we should treat high blood pressure — that part isn't really up for debate. What's individual is the target.
So do three things. Make sure your number is real — measure it properly, at home. Pull the levers you actually control. And take one question to your doctor: what's the right target for me?
References
1. https://www.nejm.org/doi/full/10.1056/NEJMoa1511939
2. https://www.ahajournals.org/doi/10.1161/HYPERTENSIONAHA.117.10479
3. https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(24)01028-6/fulltext
4. https://www.nejm.org/doi/full/10.1056/NEJMoa1001286
5. https://pubmed.ncbi.nlm.nih.gov/25685919
6. https://doi.org/10.1016/j.jamda.2018.11.003
7. https://doi.org/10.7326/0003-4819-152-6-201003160-00008
8. https://pmc.ncbi.nlm.nih.gov/articles/PMC10978147/
9. https://jamanetwork.com/journals/jama/fullarticle/2524266
10. https://doi.org/10.1016/S0140-6736(02)11911-8
11. https://doi.org/10.1001/jama.2019.14120
12. https://doi.org/10.1161/HYP.0000000000000087
13. https://doi.org/10.1161/CIR.0000000000000803
14. https://pubmed.ncbi.nlm.nih.gov/27977471
15. https://doi.org/10.1136/bjsports-2022-106503
16. https://doi.org/10.1161/01.HYP.0000094221.86888.AE
17. https://pubmed.ncbi.nlm.nih.gov/23558162
18. https://doi.org/10.1056/NEJM199704173361601
19. https://doi.org/10.1016/S2468-2667(17)30003-8
20. https://pubmed.ncbi.nlm.nih.gov/23558164
21. https://ods.od.nih.gov/factsheets/Potassium-HealthProfessional/
